The global diabetic foot ulcer treatment market is anticipated to grow at a CAGR of around 7% during the forecast period. Diabetes is one of the critical causes of various diseases in adults. A diabetic foot ulcer is a frequent complication of diabetes mellitus. Approximately 25% of diabetic patients develop a diabetic foot ulcer in the lifetime as per one of the key players B. Braun, and the risk increases with the time. The market is driven by the increasing prevalence of diabetes among people along with the growing awareness regarding diabetes.
(Get 15% Discount on Buying this Report)
Get Report Sample Copy @
https://www.omrglobal.com/request-sample/diabetic-foot-ulcer-treatment-market
National Diabetes Statistics Report (2017) by the Centers for Disease Control and Prevention (CDC) states that around 30.3 million people had diabetes which was around 9.4% of the US population. Among these, 23.1 million people were diagnosed and 7.2 million people with diabetes were undiagnosed. A growing number of diagnosed populations have a positive impact on product demand. Diabetes causes foot ulceration which creates demand for various products for the treatment of foot ulcers and hence drives the growth of the global diabetic foot ulcer market during the forecast period. However, lack of awareness among the population regarding specific treatment options may hamper the growth of the DFU treatment market.
A Full Report is Available at:
https://www.omrglobal.com/industry-reports/diabetic-foot-ulcer-treatment-market

Segmental Outlook
The global Diabetic Foot Ulcer (DFU) market is segmented based on treatment type and ulcer type. Based on the treatment type, the market is sectioned as wound care dressings, biologics, antibiotic medications, therapy devices, and others. And based on the ulcer type, the market is sectioned as neuropathic ulcers, ischemic ulcers, and neuro-ischemic ulcers.

Wound Care Dressings to Hold Significant Share in the Market
Amongst the treatment type of the market, the wound care dressings segment holds a significant share in the market during the forecast period. Wound care dressings include various types of dressings such as alginate dressings, Hydrofiber dressings, foam dressings, film dressing, hydrocolloid dressings, surgical dressings, and hydrogel dressings. Since increased cases of diabetes lead to a diabetic foot ulcer, there is an increased focus of key players in the R&D activities and developing innovative solutions for the treatment. For instance, in January 2018, Mölnlycke partnered with Tissue Analytics for the development of innovative digital solutions for wound care practitioners, which contributes towards the growth of the company as well as the market during the forecast period.

Regional Outlook
The global diabetic foot ulcer market is geographically segmented into North America, Europe, Asia-Pacific and Rest of the World. The North American region is expected to hold the most significant share in the global diabetic foot ulcer market. This is attributed to the presence of large manufacturers such as 3M Co., Cardinal Health Inc., Integra LifeSciences Corp., Medline Industries Inc., and many others. These players contribute to the market by various technological advancements and developments, and product launches to drive the growth of the diabetic foot ulcer treatment market.

Moreover, increased incidences of diabetes lead to such problems which further enhances the growth of the regional market. Asia-Pacific region is projected to grow significantly in the global diabetic foot ulcer treatment market as there is a rise in the geriatric population, which are more prone to diseases especially in countries such as India, Japan,and China during the forecast period.

Market player Outlook
The prominent players operating in the global diabetic foot ulcer market include 3M Co., B. Braun Melsungen AG, Coloplast A/S, ConvaTech Group PLC, Smith & Nephew Plc, Integra LifeSciences Corp., Mölnlycke Health Care AB, Acelity L.P. Inc., Cardinal Health Inc., and Medline Industries Inc. among others. These players are adopting various strategies such as new product launches and approvals, merger and acquisition, partnerships and collaborations, and many others in order to thrive in a competitive environment. For instance, in July 2018 Mölnlycke acquired SastoMed GmbH for the expansion of their product offerings for enhancing the wound healing process and treating chronic wounds such as diabetic foot ulcers.

The Report Covers
Market value data analysis of 2018 and forecast to 2025.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global diabetic foot ulcer treatment market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying ‘who-stands-where’ in the market.
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @
https://www.omrglobal.com/report-customization/diabetic-foot-ulcer-treatment-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404